US Stock MarketDetailed Quotes

Bio-Rad Laboratories-B (BIO.B)

Watchlist
  • 299.450
  • 0.0000.00%
Close May 1 16:00 ET
8.08BMarket Cap49.83P/E (TTM)

Bio-Rad Laboratories-B (BIO.B) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.78%108.1M
16.92%532.2M
32.77%164.9M
-26.10%120.9M
19.36%116.5M
86.10%129.9M
21.42%455.2M
53.33%124.2M
67.45%163.6M
-0.51%97.6M
Net income from continuing operations
-923.59%-527.1M
141.20%759.9M
200.59%720M
-152.34%-341.9M
114.68%317.8M
-83.33%64M
-189.38%-1.84B
-304.69%-715.8M
514.49%653.2M
-86.31%-2.17B
Depreciation and amortization
7.35%40.9M
9.10%165.4M
8.42%42.5M
13.62%44.2M
11.54%40.6M
2.70%38.1M
3.91%151.6M
5.38%39.2M
4.29%38.9M
1.68%36.4M
Other non cash items
1,271.43%9.6M
-106.67%-3.3M
-145.61%-10.9M
-87.90%3.4M
183.33%3.5M
-58.82%700K
512.50%49.5M
86.66%23.9M
223.31%28.1M
-142.21%-4.2M
Change In working capital
-486.47%-168.5M
143.88%272.4M
217.64%254.1M
-146.40%-102.4M
111.35%77.1M
-19.26%43.6M
-43.44%-620.8M
-2,534.15%-216M
8,928.00%220.7M
-77.97%-679.5M
-Change in receivables
-17.20%30.8M
20.99%19.6M
141.49%3.9M
156.76%4.2M
-484.09%-25.7M
-0.53%37.2M
42.11%16.2M
53.47%-9.4M
-128.03%-7.4M
-166.67%-4.4M
-Change in inventory
-67.04%-29.9M
710.59%68.9M
110.61%51.6M
-10.53%13.6M
196.43%21.6M
-103.41%-17.9M
118.36%8.5M
59.09%24.5M
337.50%15.2M
11.11%-22.4M
-Change in payables and accrued expense
-101.69%-600K
108.33%1.4M
186.62%12.3M
-278.80%-32.9M
-221.62%-13.5M
210.59%35.5M
77.02%-16.8M
75.13%-14.2M
243.75%18.4M
150.92%11.1M
-Change in other current assets
14.29%-4.8M
262.67%12.2M
-50.00%-4.2M
-92.02%2.1M
523.40%19.9M
78.71%-5.6M
-494.74%-7.5M
78.63%-2.8M
1,853.33%26.3M
-114.46%-4.7M
-Change in other current liabilities
141.67%2M
-103.57%-200K
-92.86%300K
-162.50%-1M
2,550.00%5.3M
-1,100.00%-4.8M
236.59%5.6M
152.50%4.2M
166.67%1.6M
-94.74%200K
-Change in other working capital
-20,650.00%-166M
127.20%170.5M
187.13%190.2M
-153.06%-88.4M
110.54%69.5M
-100.95%-800K
-94.30%-626.8M
-391.84%-218.3M
2,972.41%166.6M
-74.56%-659.3M
Cash from discontinued investing activities
Operating cash flow
-16.78%108.1M
16.92%532.2M
32.77%164.9M
-26.10%120.9M
19.36%116.5M
86.10%129.9M
21.42%455.2M
53.33%124.2M
67.43%163.6M
-0.48%97.6M
Investing cash flow
Cash flow from continuing investing activities
-3,313.79%-93.2M
-18.41%-189.7M
-12.13%-34.2M
22.80%-43M
-273.46%-115.4M
106.73%2.9M
-893.07%-160.2M
-142.25%-30.5M
-486.32%-55.7M
-210.42%-30.9M
Net PPE purchase and sale
13.08%-29.9M
4.83%-157.5M
-6.76%-45.8M
21.14%-31.7M
-8.06%-45.6M
14.43%-34.4M
-5.75%-165.5M
-1.73%-42.9M
8.65%-40.2M
-21.97%-42.2M
Net intangibles purchase and sale
----
--0
--0
----
----
----
---23.4M
--0
----
----
Net business purchase and sale
----
---218.5M
--0
---1.8M
----
----
--0
--0
--0
----
Net investment purchase and sale
-269.71%-63.3M
549.13%186.3M
-6.45%11.6M
-220.25%-9.5M
1,200.00%146.9M
1,386.21%37.3M
-83.52%28.7M
-88.91%12.4M
-77.11%7.9M
-81.94%11.3M
Cash from discontinued investing activities
Investing cash flow
-3,313.79%-93.2M
-18.41%-189.7M
-12.13%-34.2M
22.80%-43M
-273.46%-115.4M
106.73%2.9M
-893.07%-160.2M
-142.25%-30.5M
-486.32%-55.7M
-210.42%-30.9M
Financing cash flow
Cash flow from continuing financing activities
54.96%-44M
-29.43%-283.2M
112.60%3.3M
45.31%-52.5M
-41.10%-136.3M
-97.7M
48.59%-218.8M
86.94%-26.2M
-260.93%-96M
52.35%-96.6M
Net issuance payments of debt
0.00%-100K
-25.00%-500K
---200K
--0
-100.00%-200K
50.00%-100K
20.00%-400K
--0
15.25%-100K
13.79%-100K
Net common stock issuance
53.09%-47.8M
-45.14%-295.5M
--0
45.45%-53.4M
-38.81%-140.2M
-2,068.09%-101.9M
52.51%-203.6M
--0
-359.17%-97.9M
51.30%-101M
Proceeds from stock option exercised by employees
-9.30%3.9M
-17.71%15.8M
0.00%3.9M
-33.33%3.4M
-10.64%4.2M
-21.82%4.3M
3.78%19.2M
-9.97%3.9M
9.75%5.1M
-7.79%4.7M
Net other financing activities
----
91.18%-3M
98.67%-400K
19.35%-2.5M
----
----
-128.19%-34M
-529.44%-30.1M
68.39%-3.1M
---200K
Cash from discontinued financing activities
Financing cash flow
54.96%-44M
-29.43%-283.2M
112.60%3.3M
45.31%-52.5M
-41.10%-136.3M
---97.7M
48.59%-218.8M
86.94%-26.2M
-260.93%-96M
52.35%-96.6M
Net cash flow
Beginning cash position
8.66%532.2M
21.12%489.8M
-3.40%398.2M
-8.83%371.7M
20.59%523.1M
21.12%489.8M
-6.93%404.4M
-10.06%412.2M
4.41%407.7M
-6.61%433.8M
Current changes in cash
-182.91%-29.1M
-22.18%59.3M
98.52%134M
113.45%25.4M
-352.17%-135.2M
31.46%35.1M
349.84%76.2M
242.47%67.5M
-80.69%11.9M
61.01%-29.9M
Effect of exchange rate changes
427.78%5.9M
-283.70%-16.9M
--0
114.86%1.1M
-526.32%-16.2M
-166.67%-1.8M
2,200.00%9.2M
255.60%10.1M
-218.95%-7.4M
42.54%3.8M
End cash Position
-2.70%509M
8.66%532.2M
8.66%532.2M
-3.40%398.2M
-8.83%371.7M
20.59%523.1M
21.12%489.8M
21.12%489.8M
-10.06%412.2M
4.41%407.7M
Free cash flow
-18.22%78.1M
40.72%374.6M
46.49%119.1M
-10.80%89.2M
28.03%70.8M
222.64%95.5M
22.00%266.2M
109.87%81.3M
86.43%100M
-12.81%55.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.78%108.1M16.92%532.2M32.77%164.9M-26.10%120.9M19.36%116.5M86.10%129.9M21.42%455.2M53.33%124.2M67.45%163.6M-0.51%97.6M
Net income from continuing operations -923.59%-527.1M141.20%759.9M200.59%720M-152.34%-341.9M114.68%317.8M-83.33%64M-189.38%-1.84B-304.69%-715.8M514.49%653.2M-86.31%-2.17B
Depreciation and amortization 7.35%40.9M9.10%165.4M8.42%42.5M13.62%44.2M11.54%40.6M2.70%38.1M3.91%151.6M5.38%39.2M4.29%38.9M1.68%36.4M
Other non cash items 1,271.43%9.6M-106.67%-3.3M-145.61%-10.9M-87.90%3.4M183.33%3.5M-58.82%700K512.50%49.5M86.66%23.9M223.31%28.1M-142.21%-4.2M
Change In working capital -486.47%-168.5M143.88%272.4M217.64%254.1M-146.40%-102.4M111.35%77.1M-19.26%43.6M-43.44%-620.8M-2,534.15%-216M8,928.00%220.7M-77.97%-679.5M
-Change in receivables -17.20%30.8M20.99%19.6M141.49%3.9M156.76%4.2M-484.09%-25.7M-0.53%37.2M42.11%16.2M53.47%-9.4M-128.03%-7.4M-166.67%-4.4M
-Change in inventory -67.04%-29.9M710.59%68.9M110.61%51.6M-10.53%13.6M196.43%21.6M-103.41%-17.9M118.36%8.5M59.09%24.5M337.50%15.2M11.11%-22.4M
-Change in payables and accrued expense -101.69%-600K108.33%1.4M186.62%12.3M-278.80%-32.9M-221.62%-13.5M210.59%35.5M77.02%-16.8M75.13%-14.2M243.75%18.4M150.92%11.1M
-Change in other current assets 14.29%-4.8M262.67%12.2M-50.00%-4.2M-92.02%2.1M523.40%19.9M78.71%-5.6M-494.74%-7.5M78.63%-2.8M1,853.33%26.3M-114.46%-4.7M
-Change in other current liabilities 141.67%2M-103.57%-200K-92.86%300K-162.50%-1M2,550.00%5.3M-1,100.00%-4.8M236.59%5.6M152.50%4.2M166.67%1.6M-94.74%200K
-Change in other working capital -20,650.00%-166M127.20%170.5M187.13%190.2M-153.06%-88.4M110.54%69.5M-100.95%-800K-94.30%-626.8M-391.84%-218.3M2,972.41%166.6M-74.56%-659.3M
Cash from discontinued investing activities
Operating cash flow -16.78%108.1M16.92%532.2M32.77%164.9M-26.10%120.9M19.36%116.5M86.10%129.9M21.42%455.2M53.33%124.2M67.43%163.6M-0.48%97.6M
Investing cash flow
Cash flow from continuing investing activities -3,313.79%-93.2M-18.41%-189.7M-12.13%-34.2M22.80%-43M-273.46%-115.4M106.73%2.9M-893.07%-160.2M-142.25%-30.5M-486.32%-55.7M-210.42%-30.9M
Net PPE purchase and sale 13.08%-29.9M4.83%-157.5M-6.76%-45.8M21.14%-31.7M-8.06%-45.6M14.43%-34.4M-5.75%-165.5M-1.73%-42.9M8.65%-40.2M-21.97%-42.2M
Net intangibles purchase and sale ------0--0---------------23.4M--0--------
Net business purchase and sale -------218.5M--0---1.8M----------0--0--0----
Net investment purchase and sale -269.71%-63.3M549.13%186.3M-6.45%11.6M-220.25%-9.5M1,200.00%146.9M1,386.21%37.3M-83.52%28.7M-88.91%12.4M-77.11%7.9M-81.94%11.3M
Cash from discontinued investing activities
Investing cash flow -3,313.79%-93.2M-18.41%-189.7M-12.13%-34.2M22.80%-43M-273.46%-115.4M106.73%2.9M-893.07%-160.2M-142.25%-30.5M-486.32%-55.7M-210.42%-30.9M
Financing cash flow
Cash flow from continuing financing activities 54.96%-44M-29.43%-283.2M112.60%3.3M45.31%-52.5M-41.10%-136.3M-97.7M48.59%-218.8M86.94%-26.2M-260.93%-96M52.35%-96.6M
Net issuance payments of debt 0.00%-100K-25.00%-500K---200K--0-100.00%-200K50.00%-100K20.00%-400K--015.25%-100K13.79%-100K
Net common stock issuance 53.09%-47.8M-45.14%-295.5M--045.45%-53.4M-38.81%-140.2M-2,068.09%-101.9M52.51%-203.6M--0-359.17%-97.9M51.30%-101M
Proceeds from stock option exercised by employees -9.30%3.9M-17.71%15.8M0.00%3.9M-33.33%3.4M-10.64%4.2M-21.82%4.3M3.78%19.2M-9.97%3.9M9.75%5.1M-7.79%4.7M
Net other financing activities ----91.18%-3M98.67%-400K19.35%-2.5M---------128.19%-34M-529.44%-30.1M68.39%-3.1M---200K
Cash from discontinued financing activities
Financing cash flow 54.96%-44M-29.43%-283.2M112.60%3.3M45.31%-52.5M-41.10%-136.3M---97.7M48.59%-218.8M86.94%-26.2M-260.93%-96M52.35%-96.6M
Net cash flow
Beginning cash position 8.66%532.2M21.12%489.8M-3.40%398.2M-8.83%371.7M20.59%523.1M21.12%489.8M-6.93%404.4M-10.06%412.2M4.41%407.7M-6.61%433.8M
Current changes in cash -182.91%-29.1M-22.18%59.3M98.52%134M113.45%25.4M-352.17%-135.2M31.46%35.1M349.84%76.2M242.47%67.5M-80.69%11.9M61.01%-29.9M
Effect of exchange rate changes 427.78%5.9M-283.70%-16.9M--0114.86%1.1M-526.32%-16.2M-166.67%-1.8M2,200.00%9.2M255.60%10.1M-218.95%-7.4M42.54%3.8M
End cash Position -2.70%509M8.66%532.2M8.66%532.2M-3.40%398.2M-8.83%371.7M20.59%523.1M21.12%489.8M21.12%489.8M-10.06%412.2M4.41%407.7M
Free cash flow -18.22%78.1M40.72%374.6M46.49%119.1M-10.80%89.2M28.03%70.8M222.64%95.5M22.00%266.2M109.87%81.3M86.43%100M-12.81%55.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More